期刊文献+

靶向BIRC5,Bcl-2siRNA慢病毒表达载体最佳干扰序列的筛选 被引量:1

Effective Jamming Sequence Screening of the Expression Vector in Slow Virus of the Target to the siRNA of BIRC5 and Bcl-2
下载PDF
导出
摘要 目的 针对设计合成构建的BIRC5和Bcl-2小分子干扰RNA(siRNA)的慢病毒质粒表达载体进行有效靶序列筛选,探讨其对靶基因的封闭和抑制作用.方法 将BIRC5和Bcl-2 siRNA慢病毒质粒表达载体通过脂质体介导,分别转染体外培养的Tca-8113细胞.采用半定量RT-PCR检测转染细胞BIRC5和Bcl-2 mRNA表达及Western blot检测蛋白表达水平.结果 BIRC5和Bcl-2 mRNA抑制率分别为35%~76%和30%~72%,所设计的siRNA序列不同程度降低和下调其mRNA及相应的蛋白表达,实验组与对照组比较差异有统计学显著性意义(P〈0.05),阴性对照组无此作用(P〉0.05).结论 设计合成的siRNA干扰序列能抑制其靶基因mRNA和蛋白的表达,不同的干扰靶点其抑制效果不同,本实验成功筛选出两对最佳干扰序列作为对肿瘤细胞基因治疗的实验研究. Objective Through screening effect target sequence in the slow viral material particle expression vector which carry on the design and synthesis of the BIRC5 and Bcl-2 small molecules disturbs RNA (siRNA),object was to research its seal and inhibitory action in the target gene. Methods The BIRC5 and Bcl-2 siRNA in the slow virus material particle expression vector was transferred into the vitro person lingual cancer cells Tca-8113 through the lead of llpin body. The examination to the expression of BIRC5 and Bcl-2 mRNA in transfer cells was throngh the method of RT-PCR,and the examination to the expression of protein was Western blot. Results The inhibitory rates of BIRC5 and Bcl-2 mRNA were 35%- 76% and 30%-72% respectively. All the siRNA sequence could reduce and down regulate the expression of protein. At all the level,and there was significant in statistics with the comparison between the experimental group and the control group( P 〈0. 05) ,however the negative control group was noneffective(P〉0. 05). Conclusion The synthetical siRNA disturbs sequence could restrain the expression of target gene mRNA and protein,and the repressive impression varied in different target sequence. Have triumphantly obtained two effective disturbs sequence to research the therapy of lingual cancer.
出处 《现代检验医学杂志》 CAS 2011年第6期33-36,共4页 Journal of Modern Laboratory Medicine
基金 陕西省社发攻关资助项目(2009k12-01).
关键词 Tca-8113细胞 RNA干扰 BIRC5 BCL-2 Tca-8113 cells RNAi BIRC5 Bcl-2
  • 相关文献

参考文献12

  • 1饶国洲,李昂,朱永进,石建峰,苟建重,张引成.BIRC5 shRNA慢病毒表达载体的构建与鉴定[J].细胞与分子免疫学杂志,2011,27(7):767-769. 被引量:2
  • 2饶国洲,李昂,朱永进,齐红,张引成.Bcl-2shRNA慢病毒表达载体的构建与鉴定[J].陕西医学杂志,2011,40(10):1281-1284. 被引量:2
  • 3Nakagawa Y,Yamaguchi S,Hasegawa M,et al.Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia[J].Leukemia Research,2004,28(5):487-494.
  • 4Gradilone A,Gazzaniga P,Ribuffo D,et al.Survivin,bcl-2,bax,and bcl-X gene expression in sentinel lymph nodes from melanoma patients[J].Journal of Clinical Oncology,2003,21(2):306-312.
  • 5Olie RA,Hall J,Natt F,et al.Analysis of ribosyl-modified,mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide[J].Biochimica et Biophysica Acta,2002,1576(1/2):101-109.
  • 6Karlas A,Machuy N,Shin Y,et al.Genome-wide RNAi screen identifies human host factors crucial for influenza virus replicatin[J].Nature,2010,463(7282):818-822.
  • 7Kittler R,Pelletier L,Heninger AK,et al.Gemone-scale RNAi profiling of cell division in human tissue culture cells[J].Nat Cell Biol,2007,9(12):1401-1412.
  • 8Bjorklund M,Taipale M,Varjosalo M,et al.Identification of pathwarys regulating cell size and cell-cycle progression by RNAi[J].Nature,2006,439(7079):1009-1013.
  • 9Moffat J,Grueneberg DA,Yang X,et al.A lentiviral RNAi library for human and mouse gunes applied to an arrayed viral high-content screen[J].Cell,2006,124(6):1283-1298.
  • 10Krebs MD,Alsberg E.Localized,Targeted and Sustained siRNA Delivery[J].Chem Eur J,2011,17(11):3054-3062.

二级参考文献17

  • 1Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,411 (6836):494-498.
  • 2Verma NK,Dey CS.RNA-mediated gene silencing:mechanisms and its therapeutic applications[J].J Clin Pharm Ther,2004,29 (5):395-404.
  • 3Buck AC,Shen C,Schirrmeister H,et al.Liposonal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis[J].Cancer Biother Radiopharm,2002,17 (3):281-289.
  • 4Lima RT,Martins LM,Guimaraes JE,et al.Specifie downregulation of Bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells[J].Cancer Gene Ther,2004,11 (5):309-316.
  • 5Kamihira S, Yamada Y, Hirakata Y, et al. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukemia: surviving is an important determinant for prognosis[ J]. Br J Haematol, 2001, 14 (1) : 63 -69.
  • 6Ryan BM, Donovan N, Duffy MJ. Survivin: A new target for anti- cancer therapy [ J ]. Cancer Treat Rev, 2009, 35 (7) : 553 - 562.
  • 7Wang Q, Wu PC, Roberson RS. et al. Survivin and escaping in ther- apy-induced cellular senescence[J]. Int J Cancer, 2011, 128 (7) : 1546 - 1558.
  • 8Alper M, Cukur S, Belenli O, et al. Evaluation of the immunohisto- chemical stain patterns of surviving. Bak and Bag-1 in colorectal canc- ers and comparison with polyps situated in the colon [ J ]. Hepatogas- troenterology, 2008, 55 (85) : 1269 - 1273.
  • 9Chen T, Deng C. Inhibitory effect of siRNA targeting surviving in gas- tric cancer MGC-803 ceils [ J ]. Immunopharmacol, 2008, 8 ( 7 ) : 1006 - 1011.
  • 10Sun C, Cai M, Gunasekera AH, et al. NMR structure and mutage ne- sis of the inhibition of apopotosis protein XIAP [ J ]. Nature, 1999, 401 (6755) : 818 - 822.

共引文献1

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部